Gilead Sciences, Inc.
US ˙ NasdaqGS ˙ US3755581036

SecurityGILD / Gilead Sciences, Inc.
InstitutionMcIlrath & Eck, LLC
Latest Disclosed Ownership585 shares
Latest Disclosed Value $ 81,589
McIlrath & Eck, LLC ownership in GILD / Gilead Sciences, Inc.

On May 19, 2026 - McIlrath & Eck, LLC filed a 13F-HR form disclosing ownership of 585 shares of Gilead Sciences, Inc. (US:GILD) valued at $81,531 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 585 shares of Gilead Sciences, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $75,459 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-19 2026-03-31 13F GILEAD SCIENCES INC COM COMMON STOCK 375558103 585 0 0.00 82 14.08 0.0060
2026-02-03 2025-12-31 13F GILEAD SCIENCES COM 375558103 585 0 0.00 72 10.94 0.0067
2025-10-22 2025-09-30 13F GILEAD SCIENCES OM 375558103 585 0 0.00 65 0.00 0.0067
2025-08-14 2025-06-30 13F GILEAD SCIENCES COM 375558103 585 0 0.00 65 -1.54 0.0074
2025-05-16 2025-03-31 13F GILEAD SCIENCES COM 375558103 585 0 0.00 66 20.37 0.0081
2025-02-18 2024-12-31 13F GILEAD SCIENCES COM 375558103 585 0 0.00 54 10.20 0.0069
2024-11-19 2024-09-30 13F GILEAD SCIENCES COM 375558103 585 0 0.00 49 22.50 0.0063
2024-08-14 2024-06-30 13F GILEAD SCIENCES COM 375558103 585 -196 -25.10 40 -29.82 0.0060
2024-05-10 2024-03-31 13F GILEAD SCIENCES COM 375558103 781 231 42.00 57 29.55 0.0091
2024-02-06 2023-12-31 13F GILEAD SCIENCES COM 375558103 550 221 67.17 45 83.33 0.0078
2023-11-16 2023-09-30 13F GILEAD SCIENCES COM 375558103 329 -407 -55.30 25 -57.14 0.0050
2023-08-07 2023-06-30 13F GILEAD SCIENCES COM 375558103 736 0 0.00 57 -8.20 0.0119
2023-05-09 2023-03-31 13F GILEAD SCIENCES COM 375558103 736 0 0.00 61 -3.17 0.0143
2023-02-15 2022-12-31 13F GILEAD SCIENCES COM 375558103 736 173 30.73 63 80.00 0.0163
2022-10-18 2022-09-30 13F GILEAD SCIENCES COM 375558103 563 58 11.49 35 12.90 0.0096
2022-07-29 2022-06-30 13F GILEAD SCIENCES COM 375558103 505 -71 -12.33 31 -8.82 0.0096
2022-05-11 2022-03-31 13F GILEAD SCIENCES COM 375558103 576 -5 -0.86 34 -19.05 0.0098
2022-02-08 2021-12-31 13F GILEAD SCIENCES COM 375558103 581 0 0.00 42 2.44 0.0114
2021-11-12 2021-09-30 13F GILEAD SCIENCES COM 375558103 581 1 0.17 41 2.50 0.0122
2021-08-09 2021-06-30 13F GILEAD SCIENCES COM 375558103 580 1 0.17 40 8.11 0.0122
2021-05-12 2021-03-31 13F GILEAD SCIENCES COM 375558103 579 0 0.00 37 8.82 0.0129
2021-02-05 2020-12-31 13F GILEAD SCIENCES COM 375558103 579 1 0.17 34 -8.11 0.0126
2020-11-13 2020-09-30 13F GILEAD SCIENCES COM 375558103 578 12 2.12 37 -15.91 0.0158
2020-08-04 2020-06-30 13F GILEAD SCIENCES COM 375558103 566 94 19.92 44 25.71 0.0204
2020-05-14 2020-03-31 13F GILEAD SCIENCES COM 375558103 472 248 110.71 35 133.33 0.0195
2020-02-11 2019-12-31 13F GILEAD SCIENCES COM 375558103 224 0 0.00 15 7.14 0.0072
2019-11-05 2019-09-30 13F GILEAD SCIENCES COM 375558103 224 -61 -21.40 14 -22.22 0.0074
2019-08-08 2019-06-30 13F GILEAD SCIENCES COM 375558103 285 0 0.00 18 0.00 0.0100
2019-05-07 2019-03-31 13F GILEAD SCIENCES COM 375558103 285 1 0.35 18 0.00 0.0100
2019-05-07 2018-12-31 13F GILEAD SCIENCES COM 375558103 284 -32 -10.13 18 -25.00 0.0115
2018-11-13 2018-09-30 13F GILEAD SCIENCES COM 375558103 316 52 19.70 24 26.32 0.0138
2018-08-06 2018-06-30 13F GILEAD SCIENCES COM 375558103 264 -843 -76.15 19 -77.11 0.0115
2018-05-21 2018-03-31 13F GILEAD SCIENCES COM 375558103 1,107 -684 -38.19 83 -35.16 0.0486
2018-03-16 2017-12-31 13F GILEAD SCIENCES Common 375558103 1,791 1,791 128 0.0750
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.